Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1500 participants.
Also called NCT02960126
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,500 participants
- Sponsor
- Chuncheon Sacred Heart Hospital
- Registry
-
NCT02960126
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT02960126. Randomized; no masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2020-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Aspirin and Clopidogrel in the Atrial Fibrillation With Low or Moderate Stroke Risk
- Acronym
- CESAC-AF
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Chuncheon Sacred Heart Hospital
Record details
- Record id
cardio:ct-nct02960126- Content hash
1596664a8206eda2dde133bc839401567c1244febbe49084ae295ac973b1a4be